AIM: To define the clinicoradiological characteristics of skeletal muscle @entity3 from transitional cell @entity150 . MATERIALS AND METHODS: A retrospective review of all @entity1 with skeletal muscle @entity3 was undertaken between January 1999 to December 2001. @entity1 suspected of having a @entity3 on radiological examinations, and subsequently proven to have metastatic disease on histological examination were included in study. The clinical presentation and radiological features of five @entity1 with skeletal muscle @entity3 from @entity150 were reviewed from hospital records. RESULTS: Twenty-four @entity1 had skeletal muscle @entity3 from various primaries. Of these five @entity1 had previous or concurrent primary @entity5 in the bladder. @entity1 were aged between 27-70 years (mean 52 years), and all had persistent, @entity158 with or without accompanying @entity4 . The muscles involved were psoas in three @entity1 , adductor muscles of thigh in one and rectus abdominis in one. Four @entity1 had radical cystectomy with urinary diversion (two ileal conduit and two orthotopic sigmoid neobladder). One @entity1 presented with @entity150 and concomitant muscular @entity3 . All @entity1 underwent helical computed tomography (CT) before confirmation of diagnosis by fine-needle aspiration (FNA) or biopsy. The typical appearance of low-density enhancing lesions on CT was mistaken for abscess in two @entity1 and failure to respond to conservative treatment led to suspicion of @entity3 . Diagnosis was proven histologically in all @entity1 (FNA in three and biopsy in two). All @entity1 had palliative chemotherapy ( @entity1138 , @entity1891 , @entity632 and @entity786 ). Two @entity1 had local palliative 3500 rad radiotherapy for persistent @entity158 . Mean survival was 8 months (range 6-12 months). CONCLUSION: Muscular @entity3 from @entity5 typically presents with persistent @entity158 with or without @entity4 . The characteristic low-density, ring-enhancing lesions on CT in a @entity1 with previous or concomitant @entity5 should raise the suspicion of @entity3 until proven otherwise. Prognosis is dismal.

Skeletal muscle XXXX from transitional cell @entity150 : clinicoradiological features.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity632 :: ('MESH:D004317', 'Chemical') :: ['Adriamycin'] @entity5 :: ('MESH:D009369', 'Disease') :: ['urothelial tumours', 'tumours'] @entity4 :: ('MESH:D004487', 'Disease') :: ['swelling'] @entity1138 :: ('MESH:D016685', 'Chemical') :: ['Mitomycin'] @entity786 :: ('MESH:D003520', 'Chemical') :: ['Cyclophosphamide'] @entity150 :: ('MESH:D001749', 'Disease') :: ['carcinoma of the urinary bladder', 'bladder tumour', 'bladder tumours'] @entity1891 :: ('MESH:D014750', 'Chemical') :: ['Vincristine'] @entity158 :: ('MESH:D010146', 'Disease') :: ['localized pain', 'pain'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastasis']
@entity3 :: (MESH:D009362,Disease) :: ['metastasis']
